Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Fmr LLC

Fmr LLC grew its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 22.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,310 shares of the company’s stock after acquiring an additional 7,270 shares during the period. Fmr LLC owned about 0.10% of Phibro Animal Health worth $885,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. CWM LLC increased its stake in shares of Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after purchasing an additional 1,035 shares in the last quarter. Summit Securities Group LLC acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth approximately $83,000. Acadian Asset Management LLC lifted its position in shares of Phibro Animal Health by 6.3% during the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after buying an additional 42,299 shares in the last quarter. American Century Companies Inc. grew its stake in Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after acquiring an additional 189,068 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Phibro Animal Health by 5.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after acquiring an additional 42,086 shares in the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Barclays increased their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Bank of America lifted their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company. Finally, StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 6th.

Phibro Animal Health Stock Down 0.1 %

Shares of NASDAQ PAHC opened at $22.64 on Tuesday. The stock has a market cap of $916.99 million, a PE ratio of 52.56, a P/E/G ratio of 0.58 and a beta of 0.51. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. Phibro Animal Health Co. has a 12-month low of $10.03 and a 12-month high of $25.98. The company has a 50-day moving average of $23.61 and a 200 day moving average of $20.58.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be issued a $0.12 dividend. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.12%. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.